Self-assembling peptide as a candidate carrier for 5-Fluorouracil
Source abstract
Abstract
The potential application of a designed self-assembly peptide CH3CO-Pro-Thr-Phe-Cys-Phe-Lys-Phe-Glu-Pro-NH2 (named as P1) as a carrier of 5-Fluorouracil (5-Fu) for controlled release in vitro was studied. 5-Fluorouracil (5-Fu) was selected as a representative anticancer drug due to its extensive use in treating digestive system cancer and breast cancer. The interaction between P1 and 5-Fu was detected by fluorescent quenching experiments and atomic force microscopy (AFM). The quenching mechanism of 5-Fu and P1 system was dynamic by performing fluorescent quenching experiments at different temperatures. The thermodynamic analysis demonstrated that the interaction between 5-Fu and P1 was hydrophobic interaction. The complexes prepared by the interaction between peptide and 5-Fu appeared as large granular particles of about 20 nm in height under AFM (denoted as5-Fu-P1), 24 times larger than the original 5-Fu particles. According to the results, an interaction model was proposed. Furthermore, 5-Fu-P1 complexes exhibited an efficient controlled release of 5-Fu in vitro. The research suggested that P1 might be a candidate carrier for drug delivery, providing a substitution agent for 5-Fu.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (19)
Show source-provided references
1. Ruan L P, Zhang H Y, Luo H L, et al. Designed Amphiphilic Peptide Forms Stable Nanoweb, Slowly Releases Encapsulated Hydrophobic Drug, and Accelerates Animal Hemostasis[J]. Proc. Natl. Acad. Sci. USA, 2009, 106(13): 5105–511010.1073/pnas.0900026106 ↗
2. Zhang S, Holmes T, Lockshin C, et al. Spontaneous Assembly of a Self-complementary Oligopeptide to Form a Stable Macroscopic Membrane[J]. Proc. Natl. Acad. Sci. USA, 1993, 90(8): 3334–333810.1073/pnas.90.8.3334 ↗
3. Fung S Y, Yang H, Bhola P T, et al. Self-Assembling Peptide as a Potential Carrier for Hydrophobic Anticancer Drug Ellipticine: Complexation, Release and In Vitro Delivery[J]. Adv. Funct. Mater., 2009, 19(1): 74–8310.1002/adfm.200800860 ↗
4. Zhang H, Luo H, Zhao X. Mechanistic Study of Self-Assembling Peptide RADA16-I in Formation of Nanofibers and Hydrogels[J]. J. Nanotechnol. Eng. Med., 2010, 1(1): 011007–1-610.1115/1.4000301 ↗
5. Ruan L P, Luo H L, Zhang H Y, et al. Effect of Sonication on a Novel Designed Peptide[J]. Journal of Wuhan University of Technology- Mater. Sci. Ed., 2013, 28(3): 622–62610.1007/s11595-013-0741-2 ↗
6. Ruan L P, Luo H L, Zhang H Y, et al. Investigation on Structure and Properties of a Novel Designed Peptide with Half-Sequence Ionic Complement[J]. Macromol. Res., 2009, 17(8): 597–60210.1007/BF03218915 ↗
7. Ruan L P, Zhang H Y, Luo H L, et al. Application Research of a Novel Designed Peptide as a Potential Carrier[J]. Sci. China Ser. B-Chem., 2009, 52(5): 632–63810.1007/s11426-009-0033-z ↗
8. Mishra A, Loo Y, Deng R, et al. Ultrasmall Natural Peptides Selfassemble to Strong Temperature-resistant Helical Fibers in Scaffolds Suitable for Tissue Engineering[J]. Nano Today, 2011, 6(4): 232–23910.1016/j.nantod.2011.05.001 ↗
9. Qi H, Wang C, Qiu X, et al. Reagent-less Electrogenerated Chemiluminescence Peptide-based Biosensor for the Determination of Prostate-specific Antigen[J]. Talanta., 2012, 100(3): 162–16710.1016/j.talanta.2012.08.037 ↗
10. Javali N, Raj A, Saraf P, et al. Fatty Acid–RGD Peptide Amphiphile Micelles as Potential Paclitaxel Delivery Carriers to αvβ3 Integrin Overexpressing Tumors[J]. Pharm. Res., 2012, 29(12): 3347–336110.1007/s11095-012-0830-5 ↗
11. Malet-Martino M, Martino R. Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil[J]. Oncologist. 2002, 7(4): 288–32310.1634/theoncologist.7-4-288 ↗
12. Shang W, Qiao J, Gu C, et al. Anticancer Activity of an Eextract from Needles and Twigs of Taxus Cuspidata and Its Synergistic Effect as a Cocktail with 5-Fluorouracil[J]. BMC Complement Altern Med., 2011, 11(1): 1–1110.1186/1472-6882-11-123 ↗
13. Fu Y, Shyu S, Su F, et al. Development of Biodegradable Co-poly(d, llactic/ glycolic acid) Microspheres for the Controlled Release of 5-FU by the Spray Drying Method[J]. Colloids and Surfaces B: Biointerfaces, 2002. 25(4): 269–27910.1016/S0927-7765(01)00205-3 ↗
14. Ng S, Shen H, Lopez E, et al. Development of a Poly(ortho ester) Prototype with a Latent Acid in the Polymer Backbone for 5-Fluorouracil Delivery[J]. J. Control Release, 2000, 65(3): 367–37410.1016/S0168-3659(99)00218-7 ↗
15. Lakos Z, Szarka A, Koszorus L, et al. Quenching-resolved Emission Anisotropy: a Steady State Fluorescence Method to Study Protein Dynamics[J]. J. Photochem. Photobiol. B, Biol., 1995, 27(1): 55–6010.1016/1011-1344(94)07054-R ↗
16. Xie M, Xu X, Wang Y. Interaction between Hesperetin and Human Serum Albumin Revealed by Spectroscopic Methods[J]. Biochim. Biophys. Acta. (BBA), 2005, 1724(1): 215–22410.1016/j.bbagen.2005.04.009 ↗
17. Bogoeva V, Radeva M, Atanasova L, et al. Fluorescence Analysis of Hormone Binding Activities of Wheat Germ Agglutinin[J]. BBAProteins Proteomics, 2004, 1698(2): 213–21810.1016/j.bbapap.2003.12.002 ↗
18. Ross P, Subramanian S. Thermodynamics of Protein Association Reactions: Forces Contributing to Stability[J]. Biochemistry, 1981, 20(11): 3096–310210.1021/bi00514a017 ↗
19. Hu Y, Liu Y, Shen X, et al. Studies on the Interaction between 1-Hexylcarbamoyl-5-fluorouracil and Bovine Serum Albumin[J]. J. Mol. Struct., 2005, 738(1): 143–14710.1016/j.molstruc.2004.11.062 ↗